Literature DB >> 25087634

Synthesis and biological evaluation of 3-styrylchromone derivatives as free radical scavengers and α-glucosidase inhibitors.

Koichi Takao1, Ryo Ishikawa, Yoshiaki Sugita.   

Abstract

A series of 3-styrylchromone derivatives (4-20) were synthesized and the structure-activity relationships for α-glucosidase inhibition and antioxidant activities were analyzed. Among the synthesized compounds, compounds 15 and 20, which contain a catechol moiety, showed both potent 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity (15: EC₅₀=17 µM; 20: EC₅₀=23 µM) and α-glucosidase inhibitory activity (15: IC₅₀=16 µM; 20: IC₅₀=10 µM). Our data suggest that 3-styrylchromone derivatives are novel α-glucosidase inhibitors that have the potential to counteract diet-induced hyperglycemia in diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25087634     DOI: 10.1248/cpb.c14-00351

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  9 in total

1.  A theoretical evaluation on free radical scavenging activity of 3-styrylchromone derivatives: the DFT study.

Authors:  Emre Çakmak; Dilara Özbakır Işın
Journal:  J Mol Model       Date:  2020-04-11       Impact factor: 1.810

Review 2.  Styrylchromones: Biological Activities and Structure-Activity Relationship.

Authors:  Mariana Lucas; Marisa Freitas; Artur M S Silva; Eduarda Fernandes; Daniela Ribeiro
Journal:  Oxid Med Cell Longev       Date:  2021-12-22       Impact factor: 6.543

3.  Current Strategies in Development of New Chromone Derivatives with Diversified Pharmacological Activities: A Review.

Authors:  Noor Ul Amin Mohsin; Muhammad Irfan; Shams Ul Hassan; Usman Saleem
Journal:  Pharm Chem J       Date:  2020-06-15       Impact factor: 0.837

Review 4.  Isatin and its derivatives: a survey of recent syntheses, reactions, and applications.

Authors:  Rita Kakkar
Journal:  Medchemcomm       Date:  2019-01-15       Impact factor: 3.597

5.  Antioxidant Properties and Oxidative Transformation of Different Chromone Derivatives.

Authors:  Evelin Csepanyi; Peter Szabados-Furjesi; Attila Kiss-Szikszai; Lisa M Frensemeier; Uwe Karst; Istvan Lekli; David D Haines; Arpad Tosaki; Istvan Bak
Journal:  Molecules       Date:  2017-04-06       Impact factor: 4.411

6.  A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling.

Authors:  Sei-Ichi Tanuma; Takahiro Oyama; Miwa Okazawa; Hiroaki Yamazaki; Koichi Takao; Yoshiaki Sugita; Shigeru Amano; Takehiko Abe; Hiroshi Sakagami
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

7.  Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells.

Authors:  Hiroshi Sakagami; Chiyako Shimada; Yumiko Kanda; Osamu Amano; Masahiro Sugimoto; Sana Ota; Tomoyoshi Soga; Masaru Tomita; Akira Sato; Sei-Ichi Tanuma; Koichi Takao; Yoshiaki Sugita
Journal:  Toxicol Rep       Date:  2015-12-04

8.  Ionic Liquids and Ohmic Heating in Combination for Pd-catalyzed Cross-coupling Reactions: Sustainable Synthesis of Flavonoids.

Authors:  Vera L M Silva; Raquel G Soengas; Artur M S Silva
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

9.  A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling.

Authors:  Hideaki Abe; Miwa Okazawa; Takahiro Oyama; Hiroaki Yamazaki; Atsushi Yoshimori; Takanori Kamiya; Mitsutoshi Tsukimoto; Koichi Takao; Yoshiaki Sugita; Hiroshi Sakagami; Takehiko Abe; Sei-Ichi Tanuma
Journal:  Medicines (Basel)       Date:  2021-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.